Evidence mapPaperPMID 41574115Full record

ArticleFrontiers in clinical diabetes and healthcare2025

Reduction of insulin resistance in 14-15-year-old students after the COVID-19 pandemic: a prospective study from Tsunan, Japan.

Takayuki Ohno, Mizuki Ishiguro, Yuka Suganuma, Hironari Sano, Yusaku Hayashi, Rimei Nishimura

Abstract read
In one paragraph

Article in Frontiers in clinical diabetes and healthcare, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Takayuki OhnoThe Jikei University School of Medicine, Tokyo, Japan.
Mizuki IshiguroThe Jikei University School of Medicine, Tokyo, Japan.
Yuka SuganumaThe Jikei University School of Medicine, Tokyo, Japan.
Hironari SanoThe Jikei University School of Medicine, Tokyo, Japan.
Yusaku HayashiTsunan Town Hospital, Niigata, Japan.
Rimei NishimuraThe Jikei University School of Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: A significant increase in HOMA-IR values has been reported in children after the COVID-19 pandemic. This study aimed to investigate how the changes of HOMA-IR after COVID-19 was post-pandemic (2023-2024). Materials and methods: The study included 462 students aged 14-15 from Tsunan Town, Japan, who underwent health examinations between 2015 and 2024 (258 boys, 204 girls). The students' HOMA-IR, BMI, and obesity levels were studied, and temporal changes were assessed using the Kruskal-Wallis test. IR was defined as HOMA-IR ≥2.5 and temporal changes were assessed using the chi-square test. Results: A significant change in the median HOMA-IR was observed over the 10-year period (p < 0.001). The proportion of IR was significantly higher in 2020, 2021, and 2022 (p < 0.001). Conversely, no significant differences were observed in the median BMI and obesity levels over the 10-year period (p = 0.18, p = 0.13). Significant correlations were observed between HOMA-IR and BMI as well as obesity levels throughout the entire observation period and from 2015 to 2019. However, no significant correlations were observed in the years 2020-2024. Discussion: The significant increase in HOMA-IR observed after 2020 significantly decreased to values similar to pre-COVID-19 levels by 2023. However, BMI and obesity levels showed no temporal changes. Our findings suggest that changes in lifestyle due to the COVID-19 pandemic during 2020-2022 may have influenced IR in 14-15-year-old students, irrespective of obesity status.

Indexed as

COVID-19HOMA-IRinsulininsulin resistanceobesity

Identifiers

PMID41574115
PMCPMC12819293

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.